Tuberculosis Clinical Trials Database - Free Access to 552 Studies
Access comprehensive clinical trial information for Tuberculosis through Pure Global AI's free database. This collection includes 552 clinical trials across multiple phases including N/A, Phase 1, Phase 2. Currently, 75 trials are actively recruiting participants.
Research for Tuberculosis is being conducted in China, South Africa, United States of America and 7+ other countries. Leading sponsors include University of Oxford and National Institute of Allergy and Infectious Diseases (NIAID). Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Clofazimine and moxifloxacin PK, safety and AccepTAbiLitY for paediatric TB treatment (CATALYST)
Study of GeneXpert Mycobacterium Tuberculosis/ Rifampicin (MTB/RIF) Versus the Routine Methods for Detection of Mycobacterium Tuberculosis
Evaluation of CAD-based Triage for CXR Interpretation During TB Screening
A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age
Cali Sin Tos Aim 2
Precision Rifampin Trial for Personalized Dosing
Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old.
Phase I Clinical Trial to Evaluate the Safety of Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) in Healthy Adults Aged 18-65 and Patients With Pulmonary Tuberculosis
ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa
BCG Revaccination Study in Diabetic and Non-Diabetic Adults
Subclinical TB With Innovative Modified Short-course Regimens
Clinical Presentation, and Treatment Outcomes in Tuberculous Patients in Sohag Governorate
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia
Study comparing anti-tuberculosis drug levels in saliva, plasma, and urine in patients
Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults
Sensitivity and Specificity of Xpert MTB/RIF Ultra
Relevance of Isoniazid Dosage in Adults Treated for Tuberculosis
A Retrospective Study on the Treatment Pattern and Clinical Prognosis of Severe Tuberculosis Patients
Impact Evaluation of Use of MATCH AI Predictive Modelling for Identification of Hotspots for TB Active Case Finding
Evaluating Next Generation LAM Assays and Molecular Diagnostics (POC and Near POC) for the Diagnosis of TB Among People With Presumptive TB: a Prospective Multicentre Diagnostic Accuracy Study
Pure Global AI provides free access to 552 clinical trials studying Tuberculosis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include University of Oxford, National Institute of Allergy and Infectious Diseases (NIAID), Aeras, among others.